Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Neurovascular patterning cues and implications for central and peripheral neurological disease.

Gamboa NT, Taussky P, Park MS, Couldwell WT, Mahan MA, Kalani MYS.

Surg Neurol Int. 2017 Sep 6;8:208. doi: 10.4103/sni.sni_475_16. eCollection 2017. Review.

2.

Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.

Huemer F, Dejaco M, Grabmer C, Melchardt T, Neureiter D, Mayer G, Egle A, Greil R, Weiss L.

Wien Klin Wochenschr. 2017 Feb;129(3-4):141-144. doi: 10.1007/s00508-016-1124-4.

3.

Complex inheritance in Pulmonary Arterial Hypertension patients with several mutations.

Pousada G, Baloira A, Valverde D.

Sci Rep. 2016 Sep 15;6:33570. doi: 10.1038/srep33570.

4.

Genetic and epigenetic mechanisms in the development of arteriovenous malformations in the brain.

Thomas JM, Surendran S, Abraham M, Rajavelu A, Kartha CC.

Clin Epigenetics. 2016 Jul 22;8:78. doi: 10.1186/s13148-016-0248-8. eCollection 2016. Review.

5.

Targeting BMP signalling in cardiovascular disease and anaemia.

Morrell NW, Bloch DB, ten Dijke P, Goumans MJ, Hata A, Smith J, Yu PB, Bloch KD.

Nat Rev Cardiol. 2016 Feb;13(2):106-20. doi: 10.1038/nrcardio.2015.156. Epub 2015 Oct 13. Review.

6.

Ectopic Noggin in a Population of Nfatc1 Lineage Endocardial Progenitors Induces Embryonic Lethality.

Snider P, Simmons O, Wang J, Hoang CQ, Conway SJ.

J Cardiovasc Dev Dis. 2014 Dec;1(3):214-236.

7.

Pulmonary hypertension in hereditary haemorrhagic telangiectasia.

Vorselaars VM, Velthuis S, Snijder RJ, Vos JA, Mager JJ, Post MC.

World J Cardiol. 2015 May 26;7(5):230-7. doi: 10.4330/wjc.v7.i5.230.

8.

Mouse models of hereditary hemorrhagic telangiectasia: recent advances and future challenges.

Tual-Chalot S, Oh SP, Arthur HM.

Front Genet. 2015 Feb 18;6:25. doi: 10.3389/fgene.2015.00025. eCollection 2015.

9.

Neural Regulation of CNS Angiogenesis During Development.

Ma S, Huang Z.

Front Biol (Beijing). 2015 Feb;10(1):61-73.

10.

Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era.

McDonald J, Wooderchak-Donahue W, VanSant Webb C, Whitehead K, Stevenson DA, Bayrak-Toydemir P.

Front Genet. 2015 Jan 26;6:1. doi: 10.3389/fgene.2015.00001. eCollection 2015. Review.

11.

Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension.

Pousada G, Baloira A, Vilariño C, Cifrian JM, Valverde D.

PLoS One. 2014 Jun 17;9(6):e100261. doi: 10.1371/journal.pone.0100261. eCollection 2014.

12.

Connective tissue disorders and cardiovascular complications: the indomitable role of transforming growth factor-beta signaling.

Wheeler JB, Ikonomidis JS, Jones JA.

Adv Exp Med Biol. 2014;802:107-27. doi: 10.1007/978-94-007-7893-1_8. Review.

13.

Management of patients with hereditary hemorrhagic telangiectasia undergoing general anesthesia: a cohort from a single academic center's experience.

Weingarten TN, Hanson JW, Anusionwu KO, Moncrief ML, Opdahl TJ, Schneider DD, Sprung J.

J Anesth. 2013 Oct;27(5):705-11. doi: 10.1007/s00540-013-1601-0. Epub 2013 Apr 5.

14.

Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy.

Fujita E, Nakanishi T, Nishizawa T, Hagiwara N, Matsuoka R.

Heart Vessels. 2013 Nov;28(6):785-94. doi: 10.1007/s00380-013-0332-3. Epub 2013 Mar 14.

15.

An intron mutation in the ACVRL1 may be associated with a transcriptional regulation defect in a Chinese family with hereditary hemorrhagic telangiectasia.

Yu Q, Shen XH, Li Y, Li RJ, Li J, Luo YY, Liu SF, Deng MY, Pei MF, Zhang GS.

PLoS One. 2013;8(2):e58031. doi: 10.1371/journal.pone.0058031. Epub 2013 Feb 27.

16.

The complex regulation of TGF-β in cardiovascular disease.

Redondo S, Navarro-Dorado J, Ramajo M, Medina Ú, Tejerina T.

Vasc Health Risk Manag. 2012;8:533-9. doi: 10.2147/VHRM.S28041. Epub 2012 Sep 13. Review.

17.

Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: gene-phenotype correlations.

Nishida T, Faughnan ME, Krings T, Chakinala M, Gossage JR, Young WL, Kim H, Pourmohamad T, Henderson KJ, Schrum SD, James M, Quinnine N, Bharatha A, Terbrugge KG, White RI Jr.

Am J Med Genet A. 2012 Nov;158A(11):2829-34. doi: 10.1002/ajmg.a.35622. Epub 2012 Sep 18.

18.

Dynamic analysis of BMP-responsive smad activity in live zebrafish embryos.

Laux DW, Febbo JA, Roman BL.

Dev Dyn. 2011 Mar;240(3):682-94. doi: 10.1002/dvdy.22558. Epub 2011 Feb 8.

19.

Transforming growth factor-β and the hallmarks of cancer.

Tian M, Neil JR, Schiemann WP.

Cell Signal. 2011 Jun;23(6):951-62. doi: 10.1016/j.cellsig.2010.10.015. Epub 2010 Nov 6. Review.

20.

Characterization of the human Activin-A receptor type II-like kinase 1 (ACVRL1) promoter and its regulation by Sp1.

Garrido-Martin EM, Blanco FJ, Fernandez-L A, Langa C, Vary CP, Lee UE, Friedman SL, Botella LM, Bernabeu C.

BMC Mol Biol. 2010 Jun 29;11:51. doi: 10.1186/1471-2199-11-51.

Supplemental Content

Support Center